- Home
- BIVI vs FOXX Comparison
BIVI vs FOXX Comparison
Compare BIVI & FOXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIVI
- FOXX
- Stock Information
- Founded
- BIVI 2013
- FOXX 2017
- Country
- BIVI United States
- FOXX United States
- Employees
- BIVI N/A
- FOXX N/A
- Industry
- BIVI Biotechnology: Pharmaceutical Preparations
- FOXX
- Sector
- BIVI Health Care
- FOXX
- Exchange
- BIVI Nasdaq
- FOXX Nasdaq
- Market Cap
- BIVI 45.1M
- FOXX 48.8M
- IPO Year
- BIVI N/A
- FOXX N/A
- Fundamental
- Price
- BIVI $3.11
- FOXX $6.00
- Analyst Decision
- BIVI Strong Buy
- FOXX
- Analyst Count
- BIVI 2
- FOXX 0
- Target Price
- BIVI $40.00
- FOXX N/A
- AVG Volume (30 Days)
- BIVI 3.3M
- FOXX 24.9K
- Earning Date
- BIVI 11-13-2024
- FOXX 11-19-2024
- Dividend Yield
- BIVI N/A
- FOXX N/A
- EPS Growth
- BIVI N/A
- FOXX N/A
- EPS
- BIVI N/A
- FOXX N/A
- Revenue
- BIVI N/A
- FOXX $26,340,611.00
- Revenue This Year
- BIVI N/A
- FOXX N/A
- Revenue Next Year
- BIVI N/A
- FOXX N/A
- P/E Ratio
- BIVI N/A
- FOXX N/A
- Revenue Growth
- BIVI N/A
- FOXX N/A
- 52 Week Low
- BIVI $1.04
- FOXX $5.70
- 52 Week High
- BIVI $56.54
- FOXX $14.99
- Technical
- Relative Strength Index (RSI)
- BIVI 56.34
- FOXX N/A
- Support Level
- BIVI $2.87
- FOXX N/A
- Resistance Level
- BIVI $3.85
- FOXX N/A
- Average True Range (ATR)
- BIVI 0.39
- FOXX 0.00
- MACD
- BIVI 0.01
- FOXX 0.00
- Stochastic Oscillator
- BIVI 51.32
- FOXX 0.00
About BIVI BioVie Inc.
BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The Company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.
About FOXX Foxx Development Holdings Inc. Common Stock
Foxx Development Holdings Inc is a consumer electronics and integrated Internet-of-Things (IoT) solution company catering to both retail and institutional clients. With robust research and development capabilities and a strategic commitment to cultivating long-term partnerships with mobile network operators, distributors, and suppliers. Its products include tablets, smartphones, wearables, and other high-quality communication terminals.